BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Agarwal E, Brattain MG, Chowdhury S. Cell survival and metastasis regulation by Akt signaling in colorectal cancer. Cell Signal. 2013;25:1711-1719. [PMID: 23603750 DOI: 10.1016/j.cellsig.2013.03.025] [Cited by in Crossref: 103] [Cited by in F6Publishing: 97] [Article Influence: 11.4] [Reference Citation Analysis]
Number Citing Articles
1 Fan YX, Shi HY, Hu YL, Jin XL. Circ_0000144 facilitates the progression of thyroid cancer via the miR-217/AKT3 pathway. J Gene Med 2020;22:e3269. [PMID: 32890417 DOI: 10.1002/jgm.3269] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Liu J, An H, Yuan W, Feng Q, Chen L, Ma J. Prognostic Relevance and Function of MSX2 in Colorectal Cancer. J Diabetes Res 2017;2017:3827037. [PMID: 28286778 DOI: 10.1155/2017/3827037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
3 Din SRU, Nisar MA, Ramzan MN, Saleem MZ, Ghayas H, Ahmad B, Batool S, Kifayat K, Guo X, Huang M, Zhong M. Latcripin-7A from Lentinula edodes C91-3 induces apoptosis, autophagy, and cell cycle arrest at G1 phase in human gastric cancer cells via inhibiting PI3K/Akt/mTOR signaling. Eur J Pharmacol 2021;907:174305. [PMID: 34224698 DOI: 10.1016/j.ejphar.2021.174305] [Reference Citation Analysis]
4 Jiao Q, Bi L, Ren Y, Song S, Wang Q, Wang YS. Advances in studies of tyrosine kinase inhibitors and their acquired resistance. Mol Cancer 2018;17:36. [PMID: 29455664 DOI: 10.1186/s12943-018-0801-5] [Cited by in Crossref: 105] [Cited by in F6Publishing: 99] [Article Influence: 26.3] [Reference Citation Analysis]
5 Narayanan S, Fan YF, Gujarati NA, Teng QX, Wang JQ, Cai CY, Yang Y, Chintalapati AJ, Lei Y, Korlipara VL, Chen ZS. VKNG-1 Antagonizes ABCG2-Mediated Multidrug Resistance via p-AKT and Bcl-2 Pathway in Colon Cancer: In Vitro and In Vivo Study. Cancers (Basel) 2021;13:4675. [PMID: 34572902 DOI: 10.3390/cancers13184675] [Reference Citation Analysis]
6 Chen W, Qian X, Hu Y, Jin W, Shan Y, Fang X, Sun Y, Yu B, Luo Q, Xu Q. SBF-1 preferentially inhibits growth of highly malignant human liposarcoma cells. Journal of Pharmacological Sciences 2018;138:271-8. [DOI: 10.1016/j.jphs.2018.10.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
7 Pachmayr E, Treese C, Stein U. Underlying Mechanisms for Distant Metastasis - Molecular Biology. Visc Med 2017;33:11-20. [PMID: 28785563 DOI: 10.1159/000454696] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 8.4] [Reference Citation Analysis]
8 Xu W, Yang Z, Lu N. A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition. Cell Adh Migr. 2015;9:317-324. [PMID: 26241004 DOI: 10.1080/19336918.2015.1016686] [Cited by in Crossref: 222] [Cited by in F6Publishing: 233] [Article Influence: 31.7] [Reference Citation Analysis]
9 Sheng L, He P, Yang X, Zhou M, Feng Q. miR-612 negatively regulates colorectal cancer growth and metastasis by targeting AKT2. Cell Death Dis 2015;6:e1808. [PMID: 26158514 DOI: 10.1038/cddis.2015.184] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 5.7] [Reference Citation Analysis]
10 Zhou W, Tian Y, Gong H, Guo S, Luo C. Oncogenic role and therapeutic target of leptin signaling in colorectal cancer. Expert Opin Ther Targets 2014;18:961-71. [PMID: 24946986 DOI: 10.1517/14728222.2014.926889] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
11 Alkamaly OM, Altwaijry N, Sabour R, Harras MF. Dual EGFR/VEGFR2 inhibitors and apoptosis inducers: Synthesis and antitumor activity of novel pyrazoline derivatives. Arch Pharm (Weinheim) 2021;354:e2000351. [PMID: 33252142 DOI: 10.1002/ardp.202000351] [Reference Citation Analysis]
12 Chen G, Li H, Niu X, Li G, Han N, Li X, Li G, Liu Y, Sun G, Wang Y, Li Z, Li Q. Identification of key genes associated with colorectal cancer based on the transcriptional network. Pathol Oncol Res 2015;21:719-25. [PMID: 25613817 DOI: 10.1007/s12253-014-9880-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
13 Bhutani J, Sheikh A, Niazi AK. Akt inhibitors: mechanism of action and implications for anticancer therapeutics. Infect Agent Cancer 2013;8:49. [PMID: 24330834 DOI: 10.1186/1750-9378-8-49] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
14 Wang J, Li XM, Bai Z, Chi BX, Wei Y, Chen X. Curcumol induces cell cycle arrest in colon cancer cells via reactive oxygen species and Akt/ GSK3β/cyclin D1 pathway. J Ethnopharmacol 2018;210:1-9. [PMID: 28684297 DOI: 10.1016/j.jep.2017.06.037] [Cited by in Crossref: 37] [Cited by in F6Publishing: 43] [Article Influence: 7.4] [Reference Citation Analysis]
15 Yu J, Li S, Xu Z, Guo J, Li X, Wu Y, Zheng J, Sun X. CDX2 inhibits epithelial-mesenchymal transition in colorectal cancer by modulation of Snail expression and β-catenin stabilisation via transactivation of PTEN expression. Br J Cancer 2021;124:270-80. [PMID: 33239678 DOI: 10.1038/s41416-020-01148-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Agapito G, Cannataro M. Using BioPAX-Parser (BiP) to enrich lists of genes or proteins with pathway data. BMC Bioinformatics 2021;22:376. [PMID: 34592927 DOI: 10.1186/s12859-021-04297-z] [Reference Citation Analysis]
17 Zhang J, Li W, Dai S, Tai X, Jia J, Guo X. FOXQ1 is overexpressed in laryngeal carcinoma and affects cell growth, cell cycle progression and cell invasion. Oncol Lett 2015;10:2499-504. [PMID: 26622879 DOI: 10.3892/ol.2015.3530] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
18 Mahon BP, Pinard MA, McKenna R. Targeting carbonic anhydrase IX activity and expression. Molecules 2015;20:2323-48. [PMID: 25647573 DOI: 10.3390/molecules20022323] [Cited by in Crossref: 67] [Cited by in F6Publishing: 66] [Article Influence: 9.6] [Reference Citation Analysis]
19 Margaria JP, Campa CC, De Santis MC, Hirsch E, Franco I. The PI3K/Akt/mTOR pathway in polycystic kidney disease: A complex interaction with polycystins and primary cilium. Cell Signal 2020;66:109468. [PMID: 31715259 DOI: 10.1016/j.cellsig.2019.109468] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
20 Dong Y, Zhu J, Zhang M, Ge S, Zhao L. Probiotic Lactobacillus salivarius Ren prevent dimethylhydrazine-induced colorectal cancer through protein kinase B inhibition. Appl Microbiol Biotechnol 2020;104:7377-89. [PMID: 32666185 DOI: 10.1007/s00253-020-10775-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Al-Saffar NMS, Troy H, Wong Te Fong AC, Paravati R, Jackson LE, Gowan S, Boult JKR, Robinson SP, Eccles SA, Yap TA, Leach MO, Chung YL. Metabolic biomarkers of response to the AKT inhibitor MK-2206 in pre-clinical models of human colorectal and prostate carcinoma. Br J Cancer 2018;119:1118-28. [PMID: 30377337 DOI: 10.1038/s41416-018-0242-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
22 Cantor DI, Cheruku HR, Nice EC, Baker MS. Integrin αvβ6 sets the stage for colorectal cancer metastasis. Cancer Metastasis Rev 2015;34:715-34. [DOI: 10.1007/s10555-015-9591-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
23 Agarwal E, Robb CM, Smith LM, Brattain MG, Wang J, Black JD, Chowdhury S. Role of Akt2 in regulation of metastasis suppressor 1 expression and colorectal cancer metastasis. Oncogene 2017;36:3104-18. [PMID: 28068324 DOI: 10.1038/onc.2016.460] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 5.2] [Reference Citation Analysis]
24 Valacca C, Tassone E, Mignatti P. TIMP-2 Interaction with MT1-MMP Activates the AKT Pathway and Protects Tumor Cells from Apoptosis. PLoS One 2015;10:e0136797. [PMID: 26331622 DOI: 10.1371/journal.pone.0136797] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
25 Liang X, Wu P, Yang Q, Xie Y, He C, Yin L, Yin Z, Yue G, Zou Y, Li L, Song X, Lv C, Zhang W, Jing B. An update of new small-molecule anticancer drugs approved from 2015 to 2020. Eur J Med Chem 2021;220:113473. [PMID: 33906047 DOI: 10.1016/j.ejmech.2021.113473] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Zhang Q, Wei T, Shim K, Wright K, Xu K, Palka-Hamblin HL, Jurkevich A, Khare S. Atypical role of sprouty in colorectal cancer: sprouty repression inhibits epithelial-mesenchymal transition. Oncogene. 2016;35:3151-3162. [PMID: 26434583 DOI: 10.1038/onc.2015.365] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
27 Ou R, Mo L, Tang H, Leng S, Zhu H, Zhao L, Ren Y, Xu Y. circRNA-AKT1 Sequesters miR-942-5p to Upregulate AKT1 and Promote Cervical Cancer Progression. Mol Ther Nucleic Acids 2020;20:308-22. [PMID: 32193155 DOI: 10.1016/j.omtn.2020.01.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 12.0] [Reference Citation Analysis]
28 Yu J, Xu Z, Guo J, Yang K, Zheng J, Sun X. Tumor-associated macrophages (TAMs) depend on MMP1 for their cancer-promoting role. Cell Death Discov 2021;7:343. [PMID: 34753916 DOI: 10.1038/s41420-021-00730-7] [Reference Citation Analysis]
29 Sanookpan K, Nonpanya N, Sritularak B, Chanvorachote P. Ovalitenone Inhibits the Migration of Lung Cancer Cells via the Suppression of AKT/mTOR and Epithelial-to-Mesenchymal Transition. Molecules 2021;26:638. [PMID: 33530617 DOI: 10.3390/molecules26030638] [Reference Citation Analysis]
30 Yu L, Zhang J, Guo X, Li Z, Zhang P. MicroRNA-224 upregulation and AKT activation synergistically predict poor prognosis in patients with hepatocellular carcinoma. Cancer Epidemiol. 2014;38:408-413. [PMID: 24923856 DOI: 10.1016/j.canep.2014.05.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
31 Zbakh H, Zubía E, Reyes CL, Calderón-Montaño JM, Motilva V. Anticancer Activities of Meroterpenoids Isolated from the Brown Alga Cystoseira usneoides against the Human Colon Cancer Cells HT-29. Foods 2020;9:E300. [PMID: 32155797 DOI: 10.3390/foods9030300] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
32 Darwish IA, Darwish HW, Khalil NY, Sayed AYA. Experimental and Computational Evaluation of Chloranilic Acid as an Universal Chromogenic Reagent for the Development of a Novel 96-Microwell Spectrophotometric Assay for Tyrosine Kinase Inhibitors. Molecules 2021;26:744. [PMID: 33572664 DOI: 10.3390/molecules26030744] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Andrés NC, Fermento ME, Gandini NA, Romero AL, Ferro A, Donna LG, Curino AC, Facchinetti MM. Heme oxygenase-1 has antitumoral effects in colorectal cancer: involvement of p53. Exp Mol Pathol 2014;97:321-31. [PMID: 25236576 DOI: 10.1016/j.yexmp.2014.09.012] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
34 Zhu Z, Zhang X, Guo H, Fu L, Pan G, Sun Y. CXCL13-CXCR5 axis promotes the growth and invasion of colon cancer cells via PI3K/AKT pathway. Mol Cell Biochem. 2015;400:287-295. [PMID: 25476740 DOI: 10.1007/s11010-014-2285-y] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 5.4] [Reference Citation Analysis]
35 Agarwal E, Chaudhuri A, Leiphrakpam PD, Haferbier KL, Brattain MG, Chowdhury S. Akt inhibitor MK-2206 promotes anti-tumor activity and cell death by modulation of AIF and Ezrin in colorectal cancer. BMC Cancer 2014;14:145. [PMID: 24581231 DOI: 10.1186/1471-2407-14-145] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 5.0] [Reference Citation Analysis]
36 Martini M, De Santis MC, Braccini L, Gulluni F, Hirsch E. PI3K/AKT signaling pathway and cancer: an updated review. Ann Med. 2014;46:372-383. [PMID: 24897931 DOI: 10.3109/07853890.2014.912836] [Cited by in Crossref: 545] [Cited by in F6Publishing: 553] [Article Influence: 68.1] [Reference Citation Analysis]
37 Li X, Fu Q, Li H, Zhu L, Chen W, Ruan T, Xu W, Yu X. MicroRNA‐520c‐3p functions as a novel tumor suppressor in lung adenocarcinoma. FEBS J 2019. [DOI: 10.1111/febs.14835] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
38 An Q, Zhou Y, Han C, Zhou Y, Li F, Li D. BTG3 Overexpression Suppresses the Proliferation and Invasion in Epithelial Ovarian Cancer Cell by Regulating AKT/GSK3β/β-Catenin Signaling. Reprod Sci 2017;24:1462-8. [DOI: 10.1177/1933719117691143] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
39 Prasad P, Vasas A, Hohmann J, Bishayee A, Sinha D. Cirsiliol Suppressed Epithelial to Mesenchymal Transition in B16F10 Malignant Melanoma Cells through Alteration of the PI3K/Akt/NF-κB Signaling Pathway. Int J Mol Sci 2019;20:E608. [PMID: 30708951 DOI: 10.3390/ijms20030608] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
40 Li X, Li Z, Zhou W, Xing X, Huang L, Tian L, Chen J, Chen C, Ma X, Yang Z. Overexpression of 4EBP1, p70S6K, Akt1 or Akt2 differentially promotes Coxsackievirus B3-induced apoptosis in HeLa cells. Cell Death Dis 2013;4:e803-9. [PMID: 24030155 DOI: 10.1038/cddis.2013.331] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
41 Bufu T, Di X, Yilin Z, Gege L, Xi C, Ling W. Celastrol inhibits colorectal cancer cell proliferation and migration through suppression of MMP3 and MMP7 by the PI3K/AKT signaling pathway. Anticancer Drugs 2018;29:530-8. [PMID: 29553945 DOI: 10.1097/CAD.0000000000000621] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
42 Bai B, Xie B, Pan Z, Shan L, Zhao J, Zhu H. Identification of candidate genes and long non-coding RNAs associated with the effect of ATP5J in colorectal cancer. Int J Oncol 2018;52:1129-38. [PMID: 29484395 DOI: 10.3892/ijo.2018.4281] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
43 Balasuriya N, McKenna M, Liu X, Li SSC, O'Donoghue P. Phosphorylation-Dependent Inhibition of Akt1. Genes (Basel) 2018;9:E450. [PMID: 30205513 DOI: 10.3390/genes9090450] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
44 Leiphrakpam PD, Rajput A, Mathiesen M, Agarwal E, Lazenby AJ, Are C, Brattain MG, Chowdhury S. Ezrin expression and cell survival regulation in colorectal cancer. Cell Signal 2014;26:868-79. [PMID: 24462708 DOI: 10.1016/j.cellsig.2014.01.014] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
45 Velu P, Vijayalakshmi A, Vinothkumar V. Inhibiting the PI3K/Akt, NF-κB signalling pathways with syringic acid for attenuating the development of oral squamous cell carcinoma cells SCC131. J Pharm Pharmacol 2020;72:1595-606. [PMID: 32790092 DOI: 10.1111/jphp.13350] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
46 Soo HC, Chung FF, Lim KH, Yap VA, Bradshaw TD, Hii LW, Tan SH, See SJ, Tan YF, Leong CO, Mai CW. Cudraflavone C Induces Tumor-Specific Apoptosis in Colorectal Cancer Cells through Inhibition of the Phosphoinositide 3-Kinase (PI3K)-AKT Pathway. PLoS One 2017;12:e0170551. [PMID: 28107519 DOI: 10.1371/journal.pone.0170551] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 6.4] [Reference Citation Analysis]
47 Li J, Feng D, Gao C, Zhang Y, Xu J, Wu M, Zhan X. Isoforms S and L of MRPL33 from alternative splicing have isoform‑specific roles in the chemoresponse to epirubicin in gastric cancer cells via the PI3K/AKT signaling pathway. Int J Oncol 2019;54:1591-600. [PMID: 30816492 DOI: 10.3892/ijo.2019.4728] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
48 Schmidt S, Liu G, Liu G, Yang W, Honisch S, Pantelakos S, Stournaras C, Hönig A, Lang F. Enhanced Orai1 and STIM1 expression as well as store operated Ca2+ entry in therapy resistant ovary carcinoma cells. Oncotarget 2014;5:4799-810. [PMID: 25015419 DOI: 10.18632/oncotarget.2035] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 7.4] [Reference Citation Analysis]
49 Galamb O, Kalmár A, Barták BK, Patai &V, Leiszter K, Péterfia B, Wichmann B, Valcz G, Veres G, Tulassay Z, Molnár B. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma. World J Gastroenterol 2016; 22(47): 10325-10340 [PMID: 28058013 DOI: 10.3748/wjg.v22.i47.10325] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
50 Hinske LC, Heyn J, Hübner M, Rink J, Hirschberger S, Kreth S. Intronic miRNA-641 controls its host Gene's pathway PI3K/AKT and this relationship is dysfunctional in glioblastoma multiforme. Biochem Biophys Res Commun 2017;489:477-83. [PMID: 28576488 DOI: 10.1016/j.bbrc.2017.05.175] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
51 Tang Z, He Z. TIGAR promotes growth, survival and metastasis through oxidation resistance and AKT activation in glioblastoma. Oncol Lett 2019;18:2509-17. [PMID: 31402948 DOI: 10.3892/ol.2019.10574] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
52 Li Q, Ding C, Meng T, Lu W, Liu W, Hao H, Cao L. Butyrate suppresses motility of colorectal cancer cells via deactivating Akt/ERK signaling in histone deacetylase dependent manner. J Pharmacol Sci. 2017;135:148-155. [PMID: 29233468 DOI: 10.1016/j.jphs.2017.11.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 5.4] [Reference Citation Analysis]
53 Mo X, Cao Q, Liang H, Liu J, Li H, Liu F. MicroRNA-610 suppresses the proliferation of human glioblastoma cells by repressing CCND2 and AKT3. Mol Med Rep 2016;13:1961-6. [PMID: 26782072 DOI: 10.3892/mmr.2016.4760] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
54 Li H, Lu S, Chen Y, Zheng L, Chen L, Ding H, Ding J, Lou D, Liu F, Zheng B. AKT2 phosphorylation of hexokinase 2 at T473 promotes tumorigenesis and metastasis in colon cancer cells via NF-κB, HIF1α, MMP2, and MMP9 upregulation. Cell Signal 2019;58:99-110. [PMID: 30877036 DOI: 10.1016/j.cellsig.2019.03.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
55 Soares C, Melo de Lima Morais T, Carlos R, Mariano FV, Altemani A, Freire de Carvalho MG, Corrêa MB, Dias Dos Reis RR, Amorim LS, Paes de Almeida O, Jorge J. Phosphorylated Akt1 expression is associated with poor prognosis in cutaneous, oral and sinonasal melanomas. Oncotarget 2018;9:37291-304. [PMID: 30647870 DOI: 10.18632/oncotarget.26458] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
56 Silvestrini VC, Lanfredi GP, Masson AP, Poersch A, Ferreira GA, Thomé CH, Faça VM. A proteomics outlook towards the elucidation of epithelial-mesenchymal transition molecular events. Mol Omics 2019;15:316-30. [PMID: 31429845 DOI: 10.1039/c9mo00095j] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
57 Melchardt T, Magnes T, Hufnagl C, Thorner AR, Ducar M, Neureiter D, Tränkenschuh W, Klieser E, Gaggl A, Rösch S, Rasp G, Hartmann TN, Pleyer L, Rinnerthaler G, Weiss L, Greil R, Egle A. Clonal evolution and heterogeneity in metastatic head and neck cancer-An analysis of the Austrian Study Group of Medical Tumour Therapy study group. Eur J Cancer 2018;93:69-78. [PMID: 29477794 DOI: 10.1016/j.ejca.2018.01.064] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
58 Olkkonen VM. The emerging roles of OSBP-related proteins in cancer: Impacts through phosphoinositide metabolism and protein-protein interactions. Biochem Pharmacol 2021;:114455. [PMID: 33556339 DOI: 10.1016/j.bcp.2021.114455] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Tseng C, Tzeng C, Chiu C, Yang C, Lu P, Chou C, Liu C, Chen Y. Synthesis and antiproliferative evaluation of 9-methoxy-6-(piperazin-1-yl)-11H-indeno[1,2-c]quinoline-11-one derivatives. Part 4. Med Chem Commun 2014;5:937-48. [DOI: 10.1039/c4md00133h] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
60 Arora A, Taskinen JH, Olkkonen VM. Coordination of inter-organelle communication and lipid fluxes by OSBP-related proteins. Prog Lipid Res 2022;:101146. [PMID: 34999137 DOI: 10.1016/j.plipres.2022.101146] [Reference Citation Analysis]
61 Hubbard PA, Moody CL, Murali R. Allosteric modulation of Ras and the PI3K/AKT/mTOR pathway: emerging therapeutic opportunities. Front Physiol 2014;5:478. [PMID: 25566081 DOI: 10.3389/fphys.2014.00478] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
62 McKenna M, Balasuriya N, Zhong S, Li SS, O'Donoghue P. Phospho-Form Specific Substrates of Protein Kinase B (AKT1). Front Bioeng Biotechnol 2020;8:619252. [PMID: 33614606 DOI: 10.3389/fbioe.2020.619252] [Reference Citation Analysis]
63 Wu Z, Zheng X, Meng L, Fang X, He Y, Li D, Zheng C, Zhang H. α-Tocopherol, especially α-tocopherol phosphate, exerts antiapoptotic and angiogenic effects on rat bone marrow-derived endothelial progenitor cells under high-glucose and hypoxia conditions. Journal of Vascular Surgery 2018;67:1263-1273.e1. [DOI: 10.1016/j.jvs.2017.02.051] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
64 Jung CK, Jung SH, Yim SH, Jung JH, Choi HJ, Kang WK, Park SW, Oh ST, Kim JG, Lee SH, Chung YJ. Predictive microRNAs for lymph node metastasis in endoscopically resectable submucosal colorectal cancer. Oncotarget 2016;7:32902-15. [PMID: 27096956 DOI: 10.18632/oncotarget.8766] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
65 Leiphrakpam PD, Agarwal E, Mathiesen M, Haferbier KL, Brattain MG, Chowdhury S. In vivo analysis of insulin-like growth factor type 1 receptor humanized monoclonal antibody MK-0646 and small molecule kinase inhibitor OSI-906 in colorectal cancer. Oncol Rep 2014;31:87-94. [PMID: 24173770 DOI: 10.3892/or.2013.2819] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
66 Yao J, Zhang P, Li J, Xu W. MicroRNA-215 acts as a tumor suppressor in breast cancer by targeting AKT serine/threonine kinase 1. Oncol Lett 2017;14:1097-104. [PMID: 28693279 DOI: 10.3892/ol.2017.6200] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 5.4] [Reference Citation Analysis]
67 Chen Q, Sun X, Luo X, Wang J, Hu J, Feng Y. PIK3R3 inhibits cell senescence through p53/p21 signaling. Cell Death Dis 2020;11:798. [PMID: 32973127 DOI: 10.1038/s41419-020-02921-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
68 Tsai KW, Lo YH, Liu H, Yeh CY, Chen YZ, Hsu CW, Chen WS, Wang JH. Linc00659, a long noncoding RNA, acts as novel oncogene in regulating cancer cell growth in colorectal cancer. Mol Cancer 2018;17:72. [PMID: 29523145 DOI: 10.1186/s12943-018-0821-1] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 11.3] [Reference Citation Analysis]
69 Brown AS, Mohanty BK, Howe PH. Identification and characterization of an hnRNP E1 translational silencing motif. Nucleic Acids Res 2016;44:5892-907. [PMID: 27067543 DOI: 10.1093/nar/gkw241] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
70 Liang X, Yang Q, Wu P, He C, Yin L, Xu F, Yin Z, Yue G, Zou Y, Li L, Song X, Lv C, Zhang W, Jing B. The synthesis review of the approved tyrosine kinase inhibitors for anticancer therapy in 2015-2020. Bioorg Chem 2021;113:105011. [PMID: 34091289 DOI: 10.1016/j.bioorg.2021.105011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Zhang J, Zheng Z, Wu M, Zhang L, Wang J, Fu W, Xu N, Zhao Z, Lao Y, Xu H. The natural compound neobractatin inhibits tumor metastasis by upregulating the RNA-binding-protein MBNL2. Cell Death Dis 2019;10:554. [PMID: 31320607 DOI: 10.1038/s41419-019-1789-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
72 Qi SX, Sun H, Liu H, Yu J, Jiang ZY, Yan P. Role and mechanism of circ-PRKCI in hepatocellular carcinoma. World J Gastroenterol 2019; 25(16): 1964-1974 [PMID: 31086464 DOI: 10.3748/wjg.v25.i16.1964] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
73 Jung SY, Zhang ZF. The effects of genetic variants related to insulin metabolism pathways and the interactions with lifestyles on colorectal cancer risk. Menopause 2019;26:771-80. [PMID: 30649085 DOI: 10.1097/GME.0000000000001301] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
74 Buoncervello M, Romagnoli G, Buccarelli M, Fragale A, Toschi E, Parlato S, Lucchetti D, Macchia D, Spada M, Canini I, Sanchez M, Falchi M, Musella M, Biffoni M, Belardelli F, Capone I, Sgambato A, Vitiani LR, Gabriele L. IFN-α potentiates the direct and immune-mediated antitumor effects of epigenetic drugs on both metastatic and stem cells of colorectal cancer. Oncotarget 2016;7:26361-73. [PMID: 27028869 DOI: 10.18632/oncotarget.8379] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
75 Chung CZ, Balasuriya N, Manni E, Liu X, Li SS, O'Donoghue P, Heinemann IU. Gld2 activity is regulated by phosphorylation in the N-terminal domain. RNA Biol 2019;16:1022-33. [PMID: 31057087 DOI: 10.1080/15476286.2019.1608754] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
76 Zhou H, Zhang Y, Chen Q, Lin Y. AKT and JNK Signaling Pathways Increase the Metastatic Potential of Colorectal Cancer Cells by Altering Transgelin Expression. Dig Dis Sci 2016;61:1091-7. [PMID: 26694173 DOI: 10.1007/s10620-015-3985-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
77 Niveditha D, Mukherjee S, Majumder S, Chowdhury R, Chowdhury S. A global transcriptomic pipeline decoding core network of genes involved in stages leading to acquisition of drug-resistance to cisplatin in osteosarcoma cells. Bioinformatics 2019;35:1701-11. [PMID: 30307528 DOI: 10.1093/bioinformatics/bty868] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
78 Weber-Boyvat M, Kentala H, Lilja J, Vihervaara T, Hanninen R, Zhou Y, Peränen J, Nyman TA, Ivaska J, Olkkonen VM. OSBP-related protein 3 (ORP3) coupling with VAMP-associated protein A regulates R-Ras activity. Exp Cell Res 2015;331:278-91. [PMID: 25447204 DOI: 10.1016/j.yexcr.2014.10.019] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 6.1] [Reference Citation Analysis]
79 Romano G. The role of the dysfunctional akt-related pathway in cancer: establishment and maintenance of a malignant cell phenotype, resistance to therapy, and future strategies for drug development. Scientifica (Cairo) 2013;2013:317186. [PMID: 24381788 DOI: 10.1155/2013/317186] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
80 Li Q, Han Y, Du J, Jin H, Zhang J, Niu M, Qin J. Alterations of apoptosis and autophagy in developing brain of rats with epilepsy: Changes in LC3, P62, Beclin-1 and Bcl-2 levels. Neuroscience Research 2018;130:47-55. [DOI: 10.1016/j.neures.2017.08.004] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
81 Machálková M, Pavlatovská B, Michálek J, Pruška A, Štěpka K, Nečasová T, Radaszkiewicz KA, Kozubek M, Šmarda J, Preisler J, Navrátilová J. Drug Penetration Analysis in 3D Cell Cultures Using Fiducial-Based Semiautomatic Coregistration of MALDI MSI and Immunofluorescence Images. Anal Chem 2019;91:13475-84. [DOI: 10.1021/acs.analchem.9b02462] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
82 Dobashi Y, Tsubochi H, Matsubara H, Inoue J, Inazawa J, Endo S, Ooi A. Diverse involvement of isoforms and gene aberrations of Akt in human lung carcinomas. Cancer Sci 2015;106:772-81. [PMID: 25855050 DOI: 10.1111/cas.12669] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
83 Chen J, Yuan H, Talaska AE, Hill K, Sha SH. Increased Sensitivity to Noise-Induced Hearing Loss by Blockade of Endogenous PI3K/Akt Signaling. J Assoc Res Otolaryngol 2015;16:347-56. [PMID: 25790950 DOI: 10.1007/s10162-015-0508-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
84 Gao Y, Vincent DF, Davis AJ, Sansom OJ, Bartholin L, Li Q. Constitutively active transforming growth factor β receptor 1 in the mouse ovary promotes tumorigenesis. Oncotarget 2016;7:40904-18. [PMID: 27344183 DOI: 10.18632/oncotarget.10149] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
85 Darwish IA, Khalil NY, Darwish HW, Alzoman NZ, Al-Hossaini AM. Spectrophotometric and computational investigations of charge transfer complexes of chloranilic acid with tyrosine kinase inhibitors and application to development of novel universal 96-microwell assay for their determination in pharmaceutical formulations. Spectrochim Acta A Mol Biomol Spectrosc 2021;252:119482. [PMID: 33571740 DOI: 10.1016/j.saa.2021.119482] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
86 Valipour E, Nooshabadi VT, Mahdipour S, Shabani S, Farhady-Tooli L, Majidian S, Noroozi Z, Mansouri K, Motevaseli E, Modarressi MH. Anti-angiogenic effects of testis-specific gene antigen 10 on primary endothelial cells. Gene 2020;754:144856. [PMID: 32512160 DOI: 10.1016/j.gene.2020.144856] [Reference Citation Analysis]
87 Attoub S, Arafat K, Kamel Hammadi N, Mester J, Gaben AM. Akt2 knock-down reveals its contribution to human lung cancer cell proliferation, growth, motility, invasion and endothelial cell tube formation. Sci Rep 2015;5:12759. [PMID: 26234648 DOI: 10.1038/srep12759] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
88 Hamzehzadeh L, Atkin SL, Majeed M, Butler AE, Sahebkar A. The versatile role of curcumin in cancer prevention and treatment: A focus on PI3K/AKT pathway. J Cell Physiol 2018;233:6530-7. [PMID: 29693253 DOI: 10.1002/jcp.26620] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 10.5] [Reference Citation Analysis]
89 Ma J, Zhang L, Shang A, Song H, Huo J, Zhang M, Jiang L. LINC02163 promotes colorectal cancer progression via miR-511-3p/AKT3 axis. Artif Cells Nanomed Biotechnol 2020;48:961-8. [PMID: 32524841 DOI: 10.1080/21691401.2020.1773486] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
90 Hu J, Shan Y, Ma J, Pan Y, Zhou H, Jiang L, Jia L. LncRNA ST3Gal6-AS1/ST3Gal6 axis mediates colorectal cancer progression by regulating α-2,3 sialylation via PI3K/Akt signaling. Int J Cancer 2019;145:450-60. [PMID: 30613961 DOI: 10.1002/ijc.32103] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
91 Yu ACY, Chern YJ, Zhang P, Pasiliao CC, Rahman M, Chang G, Ren J, Tai IT. Inhibition of nucleophosmin 1 suppresses colorectal cancer tumor growth of patient -derived xenografts via activation of p53 and inhibition of AKT. Cancer Biol Ther 2021;22:112-23. [PMID: 33446037 DOI: 10.1080/15384047.2020.1839278] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
92 Kumar SS, Tomita Y, Wrin J, Bruhn M, Swalling A, Mohammed M, Price TJ, Hardingham JE. High early growth response 1 (EGR1) expression correlates with resistance to anti-EGFR treatment in vitro and with poorer outcome in metastatic colorectal cancer patients treated with cetuximab. Clin Transl Oncol 2017;19:718-26. [DOI: 10.1007/s12094-016-1596-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
93 Jiang N, Sun R, Sun Q. Leptin signaling molecular actions and drug target in hepatocellular carcinoma. Drug Des Devel Ther. 2014;8:2295-2302. [PMID: 25484575 DOI: 10.2147/dddt.s69004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
94 Hedrick ED, Agarwal E, Leiphrakpam PD, Haferbier KL, Brattain MG, Chowdhury S. Differential PKA activation and AKAP association determines cell fate in cancer cells. J Mol Signal 2013;8:10. [PMID: 24083380 DOI: 10.1186/1750-2187-8-10] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
95 Leoni A, Locatelli A, Morigi R, Rambaldi M. Novel thiazole derivatives: a patent review (2008 – 2012; Part 1). Expert Opinion on Therapeutic Patents 2013;24:201-16. [DOI: 10.1517/13543776.2014.858121] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
96 Tattoli I, Killackey SA, Foerster EG, Molinaro R, Maisonneuve C, Rahman MA, Winer S, Winer DA, Streutker CJ, Philpott DJ, Girardin SE. NLRX1 Acts as an Epithelial-Intrinsic Tumor Suppressor through the Modulation of TNF-Mediated Proliferation. Cell Rep 2016;14:2576-86. [PMID: 26971996 DOI: 10.1016/j.celrep.2016.02.065] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
97 Sun W, Yang J, Wang W, Hou J, Cheng Y, Fu Y, Xu Z, Cai L. The beneficial effects of Zn on Akt-mediated insulin and cell survival signaling pathways in diabetes. J Trace Elem Med Biol 2018;46:117-27. [PMID: 29413101 DOI: 10.1016/j.jtemb.2017.12.005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
98 Arun RP, Sivanesan D, Vidyasekar P, Verma RS. PTEN/FOXO3/AKT pathway regulates cell death and mediates morphogenetic differentiation of Colorectal Cancer Cells under Simulated Microgravity. Sci Rep 2017;7:5952. [PMID: 28729699 DOI: 10.1038/s41598-017-06416-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
99 Rai NK, Mathur S, Singh SK, Tiwari M, Singh VK, Haque R, Tiwari S, Kumar Sharma L. Differential regulation of mitochondrial complex I and oxidative stress based on metastatic potential of colorectal cancer cells. Oncol Lett 2020;20:313. [PMID: 33093922 DOI: 10.3892/ol.2020.12176] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
100 Zhuang J, Ye Y, Wang G, Ni J, He S, Hu C, Xia W, Lv Z. MicroRNA‑497 inhibits cellular proliferation, migration and invasion of papillary thyroid cancer by directly targeting AKT3. Mol Med Rep 2017;16:5815-22. [PMID: 28849051 DOI: 10.3892/mmr.2017.7345] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]